Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Live Attenuated Vaccines Market Size Analysis from 2022 to 2027

1.5.1 Global Live Attenuated Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Live Attenuated Vaccines Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Live Attenuated Vaccines Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Live Attenuated Vaccines Industry Impact

Chapter 2 Global Live Attenuated Vaccines Competition by Types, Applications, and Top Regions and Countries

2.1 Global Live Attenuated Vaccines (Volume and Value) by Type

2.1.1 Global Live Attenuated Vaccines Consumption and Market Share by Type (2016-2021)

2.1.2 Global Live Attenuated Vaccines Revenue and Market Share by Type (2016-2021)

2.2 Global Live Attenuated Vaccines (Volume and Value) by Application

2.2.1 Global Live Attenuated Vaccines Consumption and Market Share by Application (2016-2021)

2.2.2 Global Live Attenuated Vaccines Revenue and Market Share by Application (2016-2021)

2.3 Global Live Attenuated Vaccines (Volume and Value) by Regions

2.3.1 Global Live Attenuated Vaccines Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Live Attenuated Vaccines Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Live Attenuated Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Live Attenuated Vaccines Consumption by Regions (2016-2021)

4.2 North America Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

4.10 South America Live Attenuated Vaccines Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Live Attenuated Vaccines Market Analysis

5.1 North America Live Attenuated Vaccines Consumption and Value Analysis

5.1.1 North America Live Attenuated Vaccines Market Under COVID-19

5.2 North America Live Attenuated Vaccines Consumption Volume by Types

5.3 North America Live Attenuated Vaccines Consumption Structure by Application

5.4 North America Live Attenuated Vaccines Consumption by Top Countries

5.4.1 United States Live Attenuated Vaccines Consumption Volume from 2016 to 2021

5.4.2 Canada Live Attenuated Vaccines Consumption Volume from 2016 to 2021

5.4.3 Mexico Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 6 East Asia Live Attenuated Vaccines Market Analysis

6.1 East Asia Live Attenuated Vaccines Consumption and Value Analysis

6.1.1 East Asia Live Attenuated Vaccines Market Under COVID-19

6.2 East Asia Live Attenuated Vaccines Consumption Volume by Types

6.3 East Asia Live Attenuated Vaccines Consumption Structure by Application

6.4 East Asia Live Attenuated Vaccines Consumption by Top Countries

6.4.1 China Live Attenuated Vaccines Consumption Volume from 2016 to 2021

6.4.2 Japan Live Attenuated Vaccines Consumption Volume from 2016 to 2021

6.4.3 South Korea Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 7 Europe Live Attenuated Vaccines Market Analysis

7.1 Europe Live Attenuated Vaccines Consumption and Value Analysis

7.1.1 Europe Live Attenuated Vaccines Market Under COVID-19

7.2 Europe Live Attenuated Vaccines Consumption Volume by Types

7.3 Europe Live Attenuated Vaccines Consumption Structure by Application

7.4 Europe Live Attenuated Vaccines Consumption by Top Countries

7.4.1 Germany Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.2 UK Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.3 France Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.4 Italy Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.5 Russia Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.6 Spain Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.7 Netherlands Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.8 Switzerland Live Attenuated Vaccines Consumption Volume from 2016 to 2021

7.4.9 Poland Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 8 South Asia Live Attenuated Vaccines Market Analysis

8.1 South Asia Live Attenuated Vaccines Consumption and Value Analysis

8.1.1 South Asia Live Attenuated Vaccines Market Under COVID-19

8.2 South Asia Live Attenuated Vaccines Consumption Volume by Types

8.3 South Asia Live Attenuated Vaccines Consumption Structure by Application

8.4 South Asia Live Attenuated Vaccines Consumption by Top Countries

8.4.1 India Live Attenuated Vaccines Consumption Volume from 2016 to 2021

8.4.2 Pakistan Live Attenuated Vaccines Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Live Attenuated Vaccines Market Analysis

9.1 Southeast Asia Live Attenuated Vaccines Consumption and Value Analysis

9.1.1 Southeast Asia Live Attenuated Vaccines Market Under COVID-19

9.2 Southeast Asia Live Attenuated Vaccines Consumption Volume by Types

9.3 Southeast Asia Live Attenuated Vaccines Consumption Structure by Application

9.4 Southeast Asia Live Attenuated Vaccines Consumption by Top Countries

9.4.1 Indonesia Live Attenuated Vaccines Consumption Volume from 2016 to 2021

9.4.2 Thailand Live Attenuated Vaccines Consumption Volume from 2016 to 2021

9.4.3 Singapore Live Attenuated Vaccines Consumption Volume from 2016 to 2021

9.4.4 Malaysia Live Attenuated Vaccines Consumption Volume from 2016 to 2021

9.4.5 Philippines Live Attenuated Vaccines Consumption Volume from 2016 to 2021

9.4.6 Vietnam Live Attenuated Vaccines Consumption Volume from 2016 to 2021

9.4.7 Myanmar Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 10 Middle East Live Attenuated Vaccines Market Analysis

10.1 Middle East Live Attenuated Vaccines Consumption and Value Analysis

10.1.1 Middle East Live Attenuated Vaccines Market Under COVID-19

10.2 Middle East Live Attenuated Vaccines Consumption Volume by Types

10.3 Middle East Live Attenuated Vaccines Consumption Structure by Application

10.4 Middle East Live Attenuated Vaccines Consumption by Top Countries

10.4.1 Turkey Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.3 Iran Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.5 Israel Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.6 Iraq Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.7 Qatar Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.8 Kuwait Live Attenuated Vaccines Consumption Volume from 2016 to 2021

10.4.9 Oman Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 11 Africa Live Attenuated Vaccines Market Analysis

11.1 Africa Live Attenuated Vaccines Consumption and Value Analysis

11.1.1 Africa Live Attenuated Vaccines Market Under COVID-19

11.2 Africa Live Attenuated Vaccines Consumption Volume by Types

11.3 Africa Live Attenuated Vaccines Consumption Structure by Application

11.4 Africa Live Attenuated Vaccines Consumption by Top Countries

11.4.1 Nigeria Live Attenuated Vaccines Consumption Volume from 2016 to 2021

11.4.2 South Africa Live Attenuated Vaccines Consumption Volume from 2016 to 2021

11.4.3 Egypt Live Attenuated Vaccines Consumption Volume from 2016 to 2021

11.4.4 Algeria Live Attenuated Vaccines Consumption Volume from 2016 to 2021

11.4.5 Morocco Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 12 Oceania Live Attenuated Vaccines Market Analysis

12.1 Oceania Live Attenuated Vaccines Consumption and Value Analysis

12.2 Oceania Live Attenuated Vaccines Consumption Volume by Types

12.3 Oceania Live Attenuated Vaccines Consumption Structure by Application

12.4 Oceania Live Attenuated Vaccines Consumption by Top Countries

12.4.1 Australia Live Attenuated Vaccines Consumption Volume from 2016 to 2021

12.4.2 New Zealand Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 13 South America Live Attenuated Vaccines Market Analysis

13.1 South America Live Attenuated Vaccines Consumption and Value Analysis

13.1.1 South America Live Attenuated Vaccines Market Under COVID-19

13.2 South America Live Attenuated Vaccines Consumption Volume by Types

13.3 South America Live Attenuated Vaccines Consumption Structure by Application

13.4 South America Live Attenuated Vaccines Consumption Volume by Major Countries

13.4.1 Brazil Live Attenuated Vaccines Consumption Volume from 2016 to 2021

13.4.2 Argentina Live Attenuated Vaccines Consumption Volume from 2016 to 2021

13.4.3 Columbia Live Attenuated Vaccines Consumption Volume from 2016 to 2021

13.4.4 Chile Live Attenuated Vaccines Consumption Volume from 2016 to 2021

13.4.5 Venezuela Live Attenuated Vaccines Consumption Volume from 2016 to 2021

13.4.6 Peru Live Attenuated Vaccines Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Live Attenuated Vaccines Consumption Volume from 2016 to 2021

13.4.8 Ecuador Live Attenuated Vaccines Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Live Attenuated Vaccines Business

14.1 GlaxoSmithKline

14.1.1 GlaxoSmithKline Company Profile

14.1.2 GlaxoSmithKline Live Attenuated Vaccines Product Specification

14.1.3 GlaxoSmithKline Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Merck

14.2.1 Merck Company Profile

14.2.2 Merck Live Attenuated Vaccines Product Specification

14.2.3 Merck Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Pfizer

14.3.1 Pfizer Company Profile

14.3.2 Pfizer Live Attenuated Vaccines Product Specification

14.3.3 Pfizer Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Astellas Pharma

14.4.1 Astellas Pharma Company Profile

14.4.2 Astellas Pharma Live Attenuated Vaccines Product Specification

14.4.3 Astellas Pharma Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Johnson & Johnson

14.5.1 Johnson & Johnson Company Profile

14.5.2 Johnson & Johnson Live Attenuated Vaccines Product Specification

14.5.3 Johnson & Johnson Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 CSL

14.6.1 CSL Company Profile

14.6.2 CSL Live Attenuated Vaccines Product Specification

14.6.3 CSL Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Sanofi

14.7.1 Sanofi Company Profile

14.7.2 Sanofi Live Attenuated Vaccines Product Specification

14.7.3 Sanofi Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Serum Institute Of India

14.8.1 Serum Institute Of India Company Profile

14.8.2 Serum Institute Of India Live Attenuated Vaccines Product Specification

14.8.3 Serum Institute Of India Live Attenuated Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Live Attenuated Vaccines Market Forecast (2022-2027)

15.1 Global Live Attenuated Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Live Attenuated Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Live Attenuated Vaccines Value and Growth Rate Forecast (2022-2027)

15.2 Global Live Attenuated Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Live Attenuated Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Live Attenuated Vaccines Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Live Attenuated Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Live Attenuated Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Live Attenuated Vaccines Consumption Forecast by Type (2022-2027)

15.3.2 Global Live Attenuated Vaccines Revenue Forecast by Type (2022-2027)

15.3.3 Global Live Attenuated Vaccines Price Forecast by Type (2022-2027)

15.4 Global Live Attenuated Vaccines Consumption Volume Forecast by Application (2022-2027)

15.5 Live Attenuated Vaccines Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology